Association of serum uric acid level with non-alcoholic fatty liver disease: A cross-sectional study
Serum uric acid level has been suggested to be associated with factors that contribute to the metabolic syndrome. The aim of this study was to investigate the association of serum uric acid level with non-alcoholic fatty liver disease (NAFLD). A cross-sectional study was performed among the employee...
Saved in:
Published in | Journal of hepatology Vol. 50; no. 5; pp. 1029 - 1034 |
---|---|
Main Authors | , , , , |
Format | Journal Article |
Language | English |
Published |
Kidlington
Elsevier B.V
01.05.2009
Elsevier |
Subjects | |
Online Access | Get full text |
Cover
Loading…
Abstract | Serum uric acid level has been suggested to be associated with factors that contribute to the metabolic syndrome. The aim of this study was to investigate the association of serum uric acid level with non-alcoholic fatty liver disease (NAFLD).
A cross-sectional study was performed among the employees of Zhenhai Refining & Chemical Company Ltd., Ningbo, China.
The study included 8925 subjects (6008 men) with a mean age of 43 years. The prevalence rates of NAFLD and hyperuricemia were 11.78% and 14.71%, respectively. NAFLD patients had significantly higher serum uric acid levels than controls (370.3±86.6 vs. 321.1±82.6μmol/L; P<0.001). The prevalence rate of NAFLD was significantly higher in subjects with hyperuricemia than in those without hyperuricemia (24.75% vs. 9.54%; P<0.001), and the prevalence rate increased with progressively higher serum uric acid levels (P value for trend <0.001). Multiple regression analysis showed that hyperuricemia was associated with an increased risk of NAFLD (odds ratio [OR]: 1.291, 95% confidence interval [CI]: 1.067–1.564; P<0.001).
Serum uric acid level is significantly associated with NAFLD, and elevated serum uric acid level is an independent risk factor for NAFLD. |
---|---|
AbstractList | BACKGROUND/AIMSerum uric acid level has been suggested to be associated with factors that contribute to the metabolic syndrome. The aim of this study was to investigate the association of serum uric acid level with non-alcoholic fatty liver disease (NAFLD).METHODSA cross-sectional study was performed among the employees of Zhenhai Refining & Chemical Company Ltd., Ningbo, China.RESULTSThe study included 8925 subjects (6008 men) with a mean age of 43 years. The prevalence rates of NAFLD and hyperuricemia were 11.78% and 14.71%, respectively. NAFLD patients had significantly higher serum uric acid levels than controls (370.3+/-86.6 vs. 321.1+/-82.6 micromol/L; P<0.001). The prevalence rate of NAFLD was significantly higher in subjects with hyperuricemia than in those without hyperuricemia (24.75% vs. 9.54%; P<0.001), and the prevalence rate increased with progressively higher serum uric acid levels (P value for trend <0.001). Multiple regression analysis showed that hyperuricemia was associated with an increased risk of NAFLD (odds ratio [OR]: 1.291, 95% confidence interval [CI]: 1.067-1.564; P<0.001).CONCLUSIONSerum uric acid level is significantly associated with NAFLD, and elevated serum uric acid level is an independent risk factor for NAFLD. Background/Aim Serum uric acid level has been suggested to be associated with factors that contribute to the metabolic syndrome. The aim of this study was to investigate the association of serum uric acid level with non-alcoholic fatty liver disease (NAFLD). Methods A cross-sectional study was performed among the employees of Zhenhai Refining & Chemical Company Ltd., Ningbo, China. Results The study included 8925 subjects (6008 men) with a mean age of 43 years. The prevalence rates of NAFLD and hyperuricemia were 11.78% and 14.71%, respectively. NAFLD patients had significantly higher serum uric acid levels than controls (370.3 ± 86.6 vs . 321.1 ± 82.6 μmol/L; P < 0.001). The prevalence rate of NAFLD was significantly higher in subjects with hyperuricemia than in those without hyperuricemia (24.75% vs. 9.54%; P < 0.001), and the prevalence rate increased with progressively higher serum uric acid levels ( P value for trend < 0.001). Multiple regression analysis showed that hyperuricemia was associated with an increased risk of NAFLD (odds ratio [OR]: 1.291, 95% confidence interval [CI]: 1.067–1.564; P < 0.001). Conclusion Serum uric acid level is significantly associated with NAFLD, and elevated serum uric acid level is an independent risk factor for NAFLD. Serum uric acid level has been suggested to be associated with factors that contribute to the metabolic syndrome. The aim of this study was to investigate the association of serum uric acid level with non-alcoholic fatty liver disease (NAFLD). A cross-sectional study was performed among the employees of Zhenhai Refining & Chemical Company Ltd., Ningbo, China. The study included 8925 subjects (6008 men) with a mean age of 43 years. The prevalence rates of NAFLD and hyperuricemia were 11.78% and 14.71%, respectively. NAFLD patients had significantly higher serum uric acid levels than controls (370.3±86.6 vs. 321.1±82.6μmol/L; P<0.001). The prevalence rate of NAFLD was significantly higher in subjects with hyperuricemia than in those without hyperuricemia (24.75% vs. 9.54%; P<0.001), and the prevalence rate increased with progressively higher serum uric acid levels (P value for trend <0.001). Multiple regression analysis showed that hyperuricemia was associated with an increased risk of NAFLD (odds ratio [OR]: 1.291, 95% confidence interval [CI]: 1.067–1.564; P<0.001). Serum uric acid level is significantly associated with NAFLD, and elevated serum uric acid level is an independent risk factor for NAFLD. Serum uric acid level has been suggested to be associated with factors that contribute to the metabolic syndrome. The aim of this study was to investigate the association of serum uric acid level with non-alcoholic fatty liver disease (NAFLD). A cross-sectional study was performed among the employees of Zhenhai Refining & Chemical Company Ltd., Ningbo, China. The study included 8925 subjects (6008 men) with a mean age of 43 years. The prevalence rates of NAFLD and hyperuricemia were 11.78% and 14.71%, respectively. NAFLD patients had significantly higher serum uric acid levels than controls (370.3+/-86.6 vs. 321.1+/-82.6 micromol/L; P<0.001). The prevalence rate of NAFLD was significantly higher in subjects with hyperuricemia than in those without hyperuricemia (24.75% vs. 9.54%; P<0.001), and the prevalence rate increased with progressively higher serum uric acid levels (P value for trend <0.001). Multiple regression analysis showed that hyperuricemia was associated with an increased risk of NAFLD (odds ratio [OR]: 1.291, 95% confidence interval [CI]: 1.067-1.564; P<0.001). Serum uric acid level is significantly associated with NAFLD, and elevated serum uric acid level is an independent risk factor for NAFLD. |
Author | Xu, Lei Xu, Chengfu Li, Youming Yu, Chaohui Miao, Min |
Author_xml | – sequence: 1 givenname: Youming surname: Li fullname: Li, Youming email: xiaofu@zju.edu.cn organization: Department of Gastroenterology, The First Affiliated Hospital, College of Medicine, Zhejiang University, 79 Qingchun Road, Hangzhou 310003, PR China – sequence: 2 givenname: Chengfu surname: Xu fullname: Xu, Chengfu organization: Department of Gastroenterology, The First Affiliated Hospital, College of Medicine, Zhejiang University, 79 Qingchun Road, Hangzhou 310003, PR China – sequence: 3 givenname: Chaohui surname: Yu fullname: Yu, Chaohui organization: Department of Gastroenterology, The First Affiliated Hospital, College of Medicine, Zhejiang University, 79 Qingchun Road, Hangzhou 310003, PR China – sequence: 4 givenname: Lei surname: Xu fullname: Xu, Lei organization: Department of Gastroenterology, The First Affiliated Hospital, College of Medicine, Zhejiang University, 79 Qingchun Road, Hangzhou 310003, PR China – sequence: 5 givenname: Min surname: Miao fullname: Miao, Min organization: Department of Internal Medicine, The Hospital of Zhenhai Refining & Chemical Company, Ningbo, PR China |
BackLink | http://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=21495706$$DView record in Pascal Francis https://www.ncbi.nlm.nih.gov/pubmed/19299029$$D View this record in MEDLINE/PubMed |
BookMark | eNqFks1u1DAUhS1URKeFF2CBvIFdwrUnydgVqjSq-JMqsQAkdpZj32gcPPFgJ4Pm7XE6QxeVKCsv_J1j33PuBTkbwoCEvGRQMmDN277sN7grOYAoGSuBsydkwRqAApqKnZFFhkQh-Eqck4uUegBYgqyekXMmuZTA5YLYdUrBOD26MNDQ0YRx2tIpOkO1cZZ63KOnv924ofn1QnsTNsHn206P44F6t8dIrUuoE17RNTUxpFQkNLOh9jSNkz08J0877RO-OJ2X5PuH999uPhW3Xz5-vlnfFqaSMBa1aI3WUsuq4i3X1ggUrbW2qtpVVdul4Ubotmk6sRJ8yS1osFDXrQSoMYuWl-TN0XcXw68J06i2Lhn0Xg8YpqSaFatqBjKDr07g1G7Rql10Wx0P6m8uGXh9AnQy2ndRD8ale46zStYraDInjtzd3BE7Zdx4F-YYtfOKgZqrUr2aq1JzVYoxlavKUv5Aev-Lx0TvjiLMMe4dRpWMw8GgdTFnrmxwj8uvH8iNd4PLE_7EA6Y-TDGXlhRTiStQX-cFmvcHRDZp4Ec2uPq3wf9e_wMb19Wk |
CODEN | JOHEEC |
CitedBy_id | crossref_primary_10_12996_gmj_galenos_2023_4034 crossref_primary_10_1007_s10620_018_5242_x crossref_primary_10_1080_17843286_2020_1783907 crossref_primary_10_1186_s12876_020_01189_z crossref_primary_10_1016_j_jelechem_2016_05_038 crossref_primary_10_1371_journal_pone_0288666 crossref_primary_10_1371_journal_pone_0067152 crossref_primary_10_1021_acs_est_4c00792 crossref_primary_10_3892_br_2016_698 crossref_primary_10_1089_met_2020_0086 crossref_primary_10_3346_jkms_2011_26_3_386 crossref_primary_10_1016_j_jhep_2018_01_019 crossref_primary_10_1016_j_cgh_2021_12_002 crossref_primary_10_1016_j_ijoes_2023_100206 crossref_primary_10_1055_a_1815_7559 crossref_primary_10_1016_j_metabol_2010_08_005 crossref_primary_10_1007_s00394_009_0042_x crossref_primary_10_1007_s00394_025_03638_5 crossref_primary_10_1016_j_jhep_2015_11_022 crossref_primary_10_1155_2020_5953461 crossref_primary_10_1007_s10800_016_0947_z crossref_primary_10_1371_journal_pone_0011578 crossref_primary_10_19163_1994_9480_2022_19_2_33_42 crossref_primary_10_1038_s41598_021_88872_7 crossref_primary_10_1155_2016_3805372 crossref_primary_10_1155_2022_6687626 crossref_primary_10_3390_nu15112445 crossref_primary_10_4103_sjg_sjg_484_22 crossref_primary_10_1016_j_metabol_2012_08_013 crossref_primary_10_1186_s12944_017_0531_5 crossref_primary_10_1002_hep4_1199 crossref_primary_10_1097_MEG_0000000000000151 crossref_primary_10_3382_ps_pey596 crossref_primary_10_3389_fmed_2023_1164096 crossref_primary_10_1016_j_biopha_2019_109158 crossref_primary_10_5009_gnl_2010_4_3_378 crossref_primary_10_1016_j_clinbiochem_2015_12_010 crossref_primary_10_1097_MD_0000000000008164 crossref_primary_10_3109_03009741003742797 crossref_primary_10_1111_hepr_12146 crossref_primary_10_1038_srep37288 crossref_primary_10_1097_MD_0000000000026946 crossref_primary_10_1159_000346202 crossref_primary_10_1089_jwh_2012_4043 crossref_primary_10_1093_gastro_goaa035 crossref_primary_10_1016_j_jped_2012_12_008 crossref_primary_10_3109_13697137_2014_926323 crossref_primary_10_3390_ijms232113141 crossref_primary_10_1016_j_atherosclerosis_2018_02_014 crossref_primary_10_1155_2013_564645 crossref_primary_10_1111_j_1478_3231_2012_02842_x crossref_primary_10_1002_hep_23717 crossref_primary_10_25298_2616_5546_2019_3_2_145_150 crossref_primary_10_1007_s00592_018_1153_8 crossref_primary_10_3390_nu15133022 crossref_primary_10_1074_jbc_M114_549204 crossref_primary_10_1016_j_jceh_2015_02_006 crossref_primary_10_1007_s00204_023_03490_8 crossref_primary_10_1186_1471_230X_12_123 crossref_primary_10_5009_gnl14444 crossref_primary_10_1016_S1499_3872_11_60046_5 crossref_primary_10_1042_BCJ20190873 crossref_primary_10_1186_1476_511X_13_117 crossref_primary_10_1007_s12072_013_9482_8 crossref_primary_10_1186_s12967_018_1657_6 crossref_primary_10_1111_j_1440_1746_2010_06548_x crossref_primary_10_1517_14728222_2016_1096930 crossref_primary_10_1017_S0029665115002451 crossref_primary_10_1016_j_jfma_2012_11_014 crossref_primary_10_1016_j_jhep_2011_12_025 crossref_primary_10_1038_s41598_024_55845_5 crossref_primary_10_1152_ajpendo_00214_2013 crossref_primary_10_1186_s13098_023_00997_z crossref_primary_10_1002_advs_202104373 crossref_primary_10_1007_s11745_012_3671_4 crossref_primary_10_1097_FJC_0000000000000406 crossref_primary_10_1074_jbc_RA118_006158 crossref_primary_10_1038_srep38605 crossref_primary_10_1016_j_jpedp_2012_12_011 crossref_primary_10_1097_MD_0000000000023049 crossref_primary_10_1186_s12876_022_02263_4 crossref_primary_10_3390_pharmacy11050151 crossref_primary_10_1136_vr_101237 crossref_primary_10_1371_journal_pone_0140379 crossref_primary_10_1038_s41598_020_57784_3 crossref_primary_10_1016_j_clbc_2017_11_010 crossref_primary_10_1007_s12072_015_9682_5 crossref_primary_10_1093_toxsci_kfab034 crossref_primary_10_3390_jcm12020648 crossref_primary_10_1038_srep14325 crossref_primary_10_1371_journal_pone_0203084 crossref_primary_10_1155_2019_2763093 crossref_primary_10_1186_1471_230X_13_3 crossref_primary_10_1111_hepr_12734 crossref_primary_10_1186_s12967_022_03850_5 crossref_primary_10_1111_cen_12776 crossref_primary_10_1093_qjmed_hcv006 crossref_primary_10_1586_egh_11_19 crossref_primary_10_1111_jgh_12212 crossref_primary_10_1152_ajpendo_00518_2020 crossref_primary_10_1038_s41598_018_30267_2 crossref_primary_10_18410_jebmh_2019_543 crossref_primary_10_1097_MEG_0000000000000434 crossref_primary_10_3899_jrheum_131240 crossref_primary_10_1007_s12072_013_9453_0 crossref_primary_10_3346_jkms_2023_38_e267 crossref_primary_10_1016_j_jhep_2011_05_027 crossref_primary_10_2147_CLEP_S403314 crossref_primary_10_1155_2018_5628749 crossref_primary_10_3390_nu9080878 crossref_primary_10_1089_met_2022_0013 crossref_primary_10_3899_jrheum_180761 crossref_primary_10_1016_j_pharmthera_2024_108615 crossref_primary_10_1016_j_heliyon_2023_e18758 crossref_primary_10_1016_j_clinbiochem_2014_04_026 crossref_primary_10_1371_journal_pone_0034198 crossref_primary_10_24018_ejmed_2020_2_4_351 crossref_primary_10_3389_fendo_2024_1293850 crossref_primary_10_1016_j_jhep_2015_01_019 crossref_primary_10_3389_fendo_2024_1455132 crossref_primary_10_1155_2014_393628 crossref_primary_10_1515_CCLM_2010_037 crossref_primary_10_1136_gutjnl_2017_313884 crossref_primary_10_1016_j_arres_2022_100051 crossref_primary_10_2147_DMSO_S438975 crossref_primary_10_3390_jcm13247616 crossref_primary_10_1111_jgh_12036 crossref_primary_10_3390_ijms17040548 crossref_primary_10_1097_MD_0000000000006381 crossref_primary_10_1111_dom_15466 crossref_primary_10_1016_j_amjms_2017_03_014 crossref_primary_10_1016_j_jpba_2016_12_033 crossref_primary_10_1155_2016_1365257 crossref_primary_10_1186_s12944_018_0762_0 crossref_primary_10_3390_ijerph19031042 crossref_primary_10_1111_liv_13329 crossref_primary_10_1111_hepr_12656 crossref_primary_10_14412_1996_7012_2019_1_114_120 crossref_primary_10_1002_hep_25741 crossref_primary_10_1186_s12944_020_01288_6 crossref_primary_10_3389_fendo_2020_600472 crossref_primary_10_1016_j_cgh_2012_03_011 crossref_primary_10_1111_j_1365_2265_2011_04016_x crossref_primary_10_1007_s10620_012_2193_5 crossref_primary_10_1111_jgh_12251 crossref_primary_10_1016_j_freeradbiomed_2019_06_019 crossref_primary_10_1038_ajg_2013_104 crossref_primary_10_1155_2016_8603164 crossref_primary_10_20517_mtod_2023_41 crossref_primary_10_1016_j_cld_2012_03_005 crossref_primary_10_1186_s12944_020_01261_3 crossref_primary_10_1111_liv_12842 crossref_primary_10_1136_bmjopen_2020_048574 crossref_primary_10_3945_an_114_008144 crossref_primary_10_1186_s13027_024_00575_6 crossref_primary_10_1016_j_diabet_2010_10_009 crossref_primary_10_3389_fendo_2023_1183666 crossref_primary_10_1097_MEG_0000000000000507 crossref_primary_10_4254_wjh_v6_i5_263 crossref_primary_10_3390_nu11091987 crossref_primary_10_1590_S0004_27302013000800006 crossref_primary_10_3390_ijerph13090841 crossref_primary_10_18632_oncotarget_9691 crossref_primary_10_1038_s41598_024_74841_3 crossref_primary_10_1111_liv_15564 crossref_primary_10_3390_nu6125679 crossref_primary_10_1039_D1FO01517F crossref_primary_10_1089_end_2020_0486 crossref_primary_10_1074_jbc_M112_399899 crossref_primary_10_1007_s12072_012_9384_1 crossref_primary_10_1590_S0004_27302010000400004 crossref_primary_10_17235_reed_2019_5965_2018 crossref_primary_10_3389_fendo_2022_821689 crossref_primary_10_1111_1440_1681_12011 crossref_primary_10_1210_jc_2011_3010 crossref_primary_10_3748_wjg_v22_i5_1884 crossref_primary_10_1016_j_bioelechem_2012_05_005 crossref_primary_10_1111_j_1365_2036_2011_04788_x crossref_primary_10_3389_fendo_2020_00179 crossref_primary_10_1038_nrgastro_2013_34 crossref_primary_10_7717_peerj_7563 crossref_primary_10_1002_acr_22729 crossref_primary_10_1007_s11901_015_0264_8 crossref_primary_10_1111_ijpo_238 crossref_primary_10_1038_nrgastro_2013_41 crossref_primary_10_1016_j_ijbiomac_2014_01_025 crossref_primary_10_1016_j_jhep_2015_06_013 crossref_primary_10_1093_aje_kwr291 crossref_primary_10_1038_s41598_025_94118_7 crossref_primary_10_1371_journal_pone_0107882 crossref_primary_10_1038_srep32002 crossref_primary_10_1097_MD_0000000000004293 crossref_primary_10_1186_s12876_025_03598_4 crossref_primary_10_1186_s41043_021_00247_w crossref_primary_10_1016_j_clinbiochem_2014_01_029 crossref_primary_10_1016_j_jnutbio_2019_05_015 crossref_primary_10_1155_2014_171053 crossref_primary_10_26442_00403660_2022_02_201363 crossref_primary_10_1097_MD_0000000000000802 |
Cites_doi | 10.1016/0895-7061(96)00098-2 10.5551/jat.9.28 10.1001/jama.1993.03510030078038 10.1111/j.1365-2036.2005.02601.x 10.1111/j.1440-1746.2007.05042.x 10.1002/hep.21313 10.1016/j.atherosclerosis.2006.08.021 10.1053/jhep.2003.50161 10.1016/S1590-8658(02)80194-3 10.1111/j.1464-5491.2005.01582.x 10.1002/hep.20781 10.1001/jama.283.18.2404 10.1007/s11892-005-0020-5 10.1291/hypres.30.823 10.1152/physiol.00039.2004 10.1016/j.amjmed.2006.06.040 10.1016/j.jhep.2008.06.012 10.1016/S0021-9150(99)00214-2 10.1053/jhep.2003.50193 10.1194/jlr.M200407-JLR200 10.1161/01.HYP.0000069700.62727.C5 10.1253/circj.69.928 10.1007/BF00296994 10.1016/j.jhep.2005.02.042 10.2337/diabetes.54.12.3541 10.1097/00005344-200109000-00005 10.1080/00365520500319591 10.1111/j.1464-5491.2006.01858.x 10.1186/1743-7075-1-10 10.1016/S0026-0495(99)90163-4 10.1002/hep.20734 10.1111/j.1440-1746.2007.04952.x 10.2337/diabetes.50.8.1844 10.1016/j.jhep.2007.04.012 |
ContentType | Journal Article |
Copyright | 2008 European Association for the Study of the Liver European Association for the Study of the Liver 2009 INIST-CNRS |
Copyright_xml | – notice: 2008 European Association for the Study of the Liver – notice: European Association for the Study of the Liver – notice: 2009 INIST-CNRS |
DBID | AAYXX CITATION IQODW CGR CUY CVF ECM EIF NPM 7X8 |
DOI | 10.1016/j.jhep.2008.11.021 |
DatabaseName | CrossRef Pascal-Francis Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed MEDLINE - Academic |
DatabaseTitle | CrossRef MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) MEDLINE - Academic |
DatabaseTitleList | MEDLINE - Academic MEDLINE |
Database_xml | – sequence: 1 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Medicine |
EISSN | 1600-0641 |
EndPage | 1034 |
ExternalDocumentID | 19299029 21495706 10_1016_j_jhep_2008_11_021 S016882780800860X 1_s2_0_S016882780800860X |
Genre | Journal Article |
GroupedDBID | --- --K --M .1- .55 .FO .GJ .~1 0R~ 1B1 1P~ 1RT 1~. 1~5 29K 3O- 4.4 457 4G. 53G 5GY 5RE 5VS 7-5 71M 8P~ 9JM AABNK AAEDT AAEDW AAIKJ AAKOC AALRI AAOAW AAQFI AAQQT AAQXK AATTM AAXKI AAXUO AAYWO ABBQC ABFNM ABFRF ABJNI ABMAC ABMZM ABWVN ABXDB ACDAQ ACGFO ACGFS ACIEU ACIUM ACRLP ACRPL ACVFH ADBBV ADCNI ADEZE ADMUD ADNMO ADVLN AEBSH AEFWE AEIPS AEKER AENEX AEUPX AEVXI AFFNX AFJKZ AFPUW AFRHN AFTJW AFXIZ AGCQF AGHFR AGQPQ AGUBO AGYEJ AHHHB AIEXJ AIGII AIIUN AIKHN AITUG AJRQY AJUYK AKBMS AKRWK AKYEP ALMA_UNASSIGNED_HOLDINGS AMRAJ ANKPU ANZVX APXCP ASPBG AVWKF AXJTR AZFZN BKOJK BLXMC BNPGV CS3 D-I DU5 EBS EFJIC EFKBS EJD EO8 EO9 EP2 EP3 F5P FDB FEDTE FGOYB FIRID FNPLU FYGXN G-2 G-Q GBLVA HDZ HMK HMO HVGLF HX~ HZ~ IHE J1W KOM LZ1 M27 M41 MJL MO0 N9A O-L O9- OAUVE OC. ON0 OVD OZT P-8 P-9 P2P PC. Q38 R2- ROL RPZ SAE SCC SDF SDG SDP SEL SES SEW SPCBC SSH SSZ T5K TEORI UV1 WUQ X7M YOC Z5R ZGI ~G- AACTN AFCTW AFKWA AJOXV AMFUW RIG AAIAV ABLVK ABYKQ AHPSJ AJBFU EFLBG LCYCR AAYXX AGRNS CITATION IQODW CGR CUY CVF ECM EIF NPM 7X8 |
ID | FETCH-LOGICAL-c490t-58bcaa9a9442b2adc8e8bddd44b745d3c2c8ab66f878232d0a0d055b9005e9443 |
IEDL.DBID | .~1 |
ISSN | 0168-8278 |
IngestDate | Wed Jul 30 11:32:52 EDT 2025 Mon Jul 21 06:01:12 EDT 2025 Mon Jul 21 09:17:51 EDT 2025 Tue Jul 01 04:14:05 EDT 2025 Thu Apr 24 23:03:57 EDT 2025 Fri Feb 23 02:28:18 EST 2024 Sun Feb 23 10:19:17 EST 2025 Tue Aug 26 16:50:57 EDT 2025 |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 5 |
Keywords | SBP NAFLD PR OR LDL-C CI IQR Uric acid WC TC HDL-C SD SE DBP TG Association GGT MBP FPG Non-alcoholic fatty liver disease SUA BMI triglyceride non-alcoholic fatty liver disease prevalence ratio low-density lipoprotein cholesterol interquartile range odds ratio systolic blood pressure total cholesterol diastolic blood pressure high-density lipoprotein cholesterol serum uric acid prevalence rate waist circumference body mass index standard error confidence interval γ-glutamyltransferase fasting plasma glucose mean blood pressure standard deviation Cross sectional study Non alcoholic steatohepatitis Gastroenterology Digestive diseases Hepatic disease Serum |
Language | English |
License | https://www.elsevier.com/tdm/userlicense/1.0 CC BY 4.0 |
LinkModel | DirectLink |
MergedId | FETCHMERGED-LOGICAL-c490t-58bcaa9a9442b2adc8e8bddd44b745d3c2c8ab66f878232d0a0d055b9005e9443 |
Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 |
PMID | 19299029 |
PQID | 67145109 |
PQPubID | 23479 |
PageCount | 6 |
ParticipantIDs | proquest_miscellaneous_67145109 pubmed_primary_19299029 pascalfrancis_primary_21495706 crossref_citationtrail_10_1016_j_jhep_2008_11_021 crossref_primary_10_1016_j_jhep_2008_11_021 elsevier_sciencedirect_doi_10_1016_j_jhep_2008_11_021 elsevier_clinicalkeyesjournals_1_s2_0_S016882780800860X elsevier_clinicalkey_doi_10_1016_j_jhep_2008_11_021 |
ProviderPackageCode | CITATION AAYXX |
PublicationCentury | 2000 |
PublicationDate | 2009-05-01 |
PublicationDateYYYYMMDD | 2009-05-01 |
PublicationDate_xml | – month: 05 year: 2009 text: 2009-05-01 day: 01 |
PublicationDecade | 2000 |
PublicationPlace | Kidlington |
PublicationPlace_xml | – name: Kidlington – name: Netherlands |
PublicationTitle | Journal of hepatology |
PublicationTitleAlternate | J Hepatol |
PublicationYear | 2009 |
Publisher | Elsevier B.V Elsevier |
Publisher_xml | – name: Elsevier B.V – name: Elsevier |
References | Choi, Ford (bib10) 2007; 120 Targher, Arcaro (bib34) 2007; 191 Johnson, Kang, Feig, Kivlighn, Kanellis, Watanabe (bib36) 2003; 41 Waring, Webb, Maxwell (bib28) 2001; 38 Alberti, Zimmet, Shaw (bib14) 2006; 23 Hayden, Tyagi (bib31) 2004; 1 Rahmouni, Haynes (bib25) 2005; 5 Lonardo, Loria, Leonardi, Borsatti, Neri, Pulvirenti (bib11) 2002; 34 Villanova, Moscatiello, Ramilli, Bugianesi, Magalotti, Vanni (bib33) 2005; 42 Neuschwander-Tetri, Caldwell (bib2) 2003; 37 Fang, Alderman (bib18) 2000; 283 Garcia-Ruiz, Rodriguez-Juan, Diaz-Sanjuan, del Hoyo, Colina, Munoz-Yague (bib30) 2006; 44 Amarapurkar, Hashimoto, Lesmana, Sollano, Chen, Goh (bib4) 2007; 22 Muscelli, Natali, Bianchi, Bigazzi, Galvan, Sironi (bib22) 1996; 9 Hediger, Johnson, Miyazaki, Endou (bib7) 2005; 20 Nieto, Iribarren, Gross, Comstock, Cutler (bib27) 2000; 148 Cerda, Perez-Ayuso, Riquelme, Soza, Villaseca, Sir-Petermann (bib17) 2007; 47 Jimba, Nakagami, Takahashi, Wakamatsu, Hirota, Iwamoto (bib1) 2005; 22 Albano, Mottaran, Occhino, Reale, Vidali (bib29) 2005; 22 Suppl 2 Fan, Zhu, Li, Chen, Li, Dai (bib3) 2005; 43 Patterson, Horsley, Leake (bib32) 2003; 44 Marchesini, Bugianesi, Forlani, Cerrelli, Lenzi, Manini (bib5) 2003; 37 Quinones Galvan, Natali, Baldi, Frascerra, Sanna, Ciociaro (bib21) 1995; 268 Baba, Amasaki, Soda, Hida, Imaizumi, Ichimaru (bib13) 2007; 30 Lee, Jin Kim, Yong Jeon, Hoi Kim, Woo Oh, Park (bib12) 2006; 41 Sookoian, Pirola (bib35) 2008; 49 Targher, Bertolini, Poli, Rodella, Scala, Tessari (bib15) 2005; 54 Fruehwald-Schultes, Peters, Kern, Beyer, Pfutzner (bib23) 1999; 48 Marchesini, Brizi, Bianchi, Tomassetti, Bugianesi, Lenzi (bib6) 2001; 50 Matsubara, Chiba, Maruoka, Katayose (bib24) 2002; 9 Fan, Saibara, Chitturi, Kim, Sung, Chutaputti (bib19) 2007; 22 Bedogni, Miglioli, Masutti, Tiribelli, Marchesini, Bellentani (bib16) 2005; 42 Modan, Halkin, Karasik, Lusky (bib20) 1987; 30 Yoo, Sung, Shin, Kim, Kim, Kang (bib8) 2005; 69 Hjortnaes, Algra, Olijhoek, Huisman, Jacobs, van der Graaf (bib9) 2007; 34 Cappuccio, Strazzullo, Farinaro, Trevisan (bib26) 1993; 270 Amarapurkar (10.1016/j.jhep.2008.11.021_bib4) 2007; 22 Villanova (10.1016/j.jhep.2008.11.021_bib33) 2005; 42 Jimba (10.1016/j.jhep.2008.11.021_bib1) 2005; 22 Alberti (10.1016/j.jhep.2008.11.021_bib14) 2006; 23 Marchesini (10.1016/j.jhep.2008.11.021_bib5) 2003; 37 Marchesini (10.1016/j.jhep.2008.11.021_bib6) 2001; 50 Lee (10.1016/j.jhep.2008.11.021_bib12) 2006; 41 Baba (10.1016/j.jhep.2008.11.021_bib13) 2007; 30 Matsubara (10.1016/j.jhep.2008.11.021_bib24) 2002; 9 Rahmouni (10.1016/j.jhep.2008.11.021_bib25) 2005; 5 Quinones Galvan (10.1016/j.jhep.2008.11.021_bib21) 1995; 268 Albano (10.1016/j.jhep.2008.11.021_bib29) 2005; 22 Suppl 2 Lonardo (10.1016/j.jhep.2008.11.021_bib11) 2002; 34 Cappuccio (10.1016/j.jhep.2008.11.021_bib26) 1993; 270 Cerda (10.1016/j.jhep.2008.11.021_bib17) 2007; 47 Hediger (10.1016/j.jhep.2008.11.021_bib7) 2005; 20 Targher (10.1016/j.jhep.2008.11.021_bib15) 2005; 54 Hayden (10.1016/j.jhep.2008.11.021_bib31) 2004; 1 Patterson (10.1016/j.jhep.2008.11.021_bib32) 2003; 44 Fruehwald-Schultes (10.1016/j.jhep.2008.11.021_bib23) 1999; 48 Targher (10.1016/j.jhep.2008.11.021_bib34) 2007; 191 Hjortnaes (10.1016/j.jhep.2008.11.021_bib9) 2007; 34 Choi (10.1016/j.jhep.2008.11.021_bib10) 2007; 120 Yoo (10.1016/j.jhep.2008.11.021_bib8) 2005; 69 Fan (10.1016/j.jhep.2008.11.021_bib3) 2005; 43 Fan (10.1016/j.jhep.2008.11.021_bib19) 2007; 22 Nieto (10.1016/j.jhep.2008.11.021_bib27) 2000; 148 Sookoian (10.1016/j.jhep.2008.11.021_bib35) 2008; 49 Fang (10.1016/j.jhep.2008.11.021_bib18) 2000; 283 Johnson (10.1016/j.jhep.2008.11.021_bib36) 2003; 41 Neuschwander-Tetri (10.1016/j.jhep.2008.11.021_bib2) 2003; 37 Modan (10.1016/j.jhep.2008.11.021_bib20) 1987; 30 Garcia-Ruiz (10.1016/j.jhep.2008.11.021_bib30) 2006; 44 Bedogni (10.1016/j.jhep.2008.11.021_bib16) 2005; 42 Muscelli (10.1016/j.jhep.2008.11.021_bib22) 1996; 9 Waring (10.1016/j.jhep.2008.11.021_bib28) 2001; 38 |
References_xml | – volume: 44 start-page: 512 year: 2003 end-page: 521 ident: bib32 article-title: Prooxidant and antioxidant properties of human serum ultrafiltrates toward LDL: important role of uric acid publication-title: J Lipid Res – volume: 148 start-page: 131 year: 2000 end-page: 139 ident: bib27 article-title: Uric acid and serum antioxidant capacity: a reaction to atherosclerosis? publication-title: Atherosclerosis – volume: 9 start-page: 28 year: 2002 end-page: 34 ident: bib24 article-title: Elevated serum leptin concentrations in women with hyperuricemia publication-title: J Atheroscler Thromb – volume: 1 start-page: 10 year: 2004 ident: bib31 article-title: Uric acid: A new look at an old risk marker for cardiovascular disease, metabolic syndrome, and type 2 diabetes mellitus: The urate redox shuttle publication-title: Nutr Metab (Lond) – volume: 23 start-page: 469 year: 2006 end-page: 480 ident: bib14 article-title: Metabolic syndrome-a new world-wide definition. A Consensus Statement from the International Diabetes Federation publication-title: Diabet Med – volume: 5 start-page: 260 year: 2005 end-page: 266 ident: bib25 article-title: Endothelial effects of leptin: implications in health and diseases publication-title: Curr Diab Rep – volume: 30 start-page: 713 year: 1987 end-page: 718 ident: bib20 article-title: Elevated serum uric acid–a facet of hyperinsulinaemia publication-title: Diabetologia – volume: 37 start-page: 917 year: 2003 end-page: 923 ident: bib5 article-title: Nonalcoholic fatty liver, steatohepatitis, and the metabolic syndrome publication-title: Hepatology – volume: 38 start-page: 365 year: 2001 end-page: 371 ident: bib28 article-title: Systemic uric acid administration increases serum antioxidant capacity in healthy volunteers publication-title: J Cardiovasc Pharmacol – volume: 43 start-page: 508 year: 2005 end-page: 514 ident: bib3 article-title: Prevalence of and risk factors for fatty liver in a general population of Shanghai, China publication-title: J Hepatol – volume: 22 Suppl 2 start-page: 71 year: 2005 end-page: 73 ident: bib29 article-title: Review article: role of oxidative stress in the progression of non-alcoholic steatosis publication-title: Aliment Pharmacol Ther – volume: 22 start-page: 794 year: 2007 end-page: 800 ident: bib19 article-title: What are the risk factors and settings for non-alcoholic fatty liver disease in Asia-Pacific? publication-title: J Gastroenterol Hepatol – volume: 48 start-page: 677 year: 1999 end-page: 680 ident: bib23 article-title: Serum leptin is associated with serum uric acid concentrations in humans publication-title: Metabolism – volume: 22 start-page: 1141 year: 2005 end-page: 1145 ident: bib1 article-title: Prevalence of non-alcoholic fatty liver disease and its association with impaired glucose metabolism in Japanese adults publication-title: Diabet Med – volume: 22 start-page: 788 year: 2007 end-page: 793 ident: bib4 article-title: How common is non-alcoholic fatty liver disease in the Asia-Pacific region and are there local differences? publication-title: J Gastroenterol Hepatol – volume: 270 start-page: 354 year: 1993 end-page: 359 ident: bib26 article-title: Uric acid metabolism and tubular sodium handling. Results from a population-based study publication-title: JAMA – volume: 20 start-page: 125 year: 2005 end-page: 133 ident: bib7 article-title: Molecular physiology of urate transport publication-title: Physiology (Bethesda) – volume: 44 start-page: 581 year: 2006 end-page: 591 ident: bib30 article-title: Uric acid and anti-TNF antibody improve mitochondrial dysfunction in ob/ob mice publication-title: Hepatology – volume: 37 start-page: 1202 year: 2003 end-page: 1219 ident: bib2 article-title: Nonalcoholic steatohepatitis: summary of an AASLD Single Topic Conference publication-title: Hepatology – volume: 50 start-page: 1844 year: 2001 end-page: 1850 ident: bib6 article-title: Nonalcoholic fatty liver disease: a feature of the metabolic syndrome publication-title: Diabetes – volume: 283 start-page: 2404 year: 2000 end-page: 2410 ident: bib18 article-title: Serum uric acid and cardiovascular mortality the NHANES I epidemiologic follow-up study, 1971-1992. National Health and Nutrition Examination Survey publication-title: JAMA – volume: 49 start-page: 600 year: 2008 end-page: 607 ident: bib35 article-title: Non-alcoholic fatty liver disease is strongly associated with carotid atherosclerosis: A systematic review publication-title: J Hepatol – volume: 9 start-page: 746 year: 1996 end-page: 752 ident: bib22 article-title: Effect of insulin on renal sodium and uric acid handling in essential hypertension publication-title: Am J Hypertens – volume: 120 start-page: 442 year: 2007 end-page: 447 ident: bib10 article-title: Prevalence of the metabolic syndrome in individuals with hyperuricemia publication-title: Am J Med – volume: 47 start-page: 412 year: 2007 end-page: 417 ident: bib17 article-title: Nonalcoholic fatty liver disease in women with polycystic ovary syndrome publication-title: J Hepatol – volume: 54 start-page: 3541 year: 2005 end-page: 3546 ident: bib15 article-title: Nonalcoholic fatty liver disease and risk of future cardiovascular events among type 2 diabetic patients publication-title: Diabetes – volume: 69 start-page: 928 year: 2005 end-page: 933 ident: bib8 article-title: Relationship between serum uric acid concentration and insulin resistance and metabolic syndrome publication-title: Circ J – volume: 41 start-page: 566 year: 2006 end-page: 572 ident: bib12 article-title: Obesity is the only independent factor associated with ultrasound-diagnosed non-alcoholic fatty liver disease: a cross-sectional case-control study publication-title: Scand J Gastroenterol – volume: 42 start-page: 44 year: 2005 end-page: 52 ident: bib16 article-title: Prevalence of and risk factors for nonalcoholic fatty liver disease: the Dionysos nutrition and liver study publication-title: Hepatology – volume: 42 start-page: 473 year: 2005 end-page: 480 ident: bib33 article-title: Endothelial dysfunction and cardiovascular risk profile in nonalcoholic fatty liver disease publication-title: Hepatology – volume: 41 start-page: 1183 year: 2003 end-page: 1190 ident: bib36 article-title: Is there a pathogenetic role for uric acid in hypertension and cardiovascular and renal disease? publication-title: Hypertension – volume: 34 start-page: 1882 year: 2007 end-page: 1887 ident: bib9 article-title: Serum uric acid levels and risk for vascular diseases in patients with metabolic syndrome publication-title: J Rheumatol – volume: 30 start-page: 823 year: 2007 end-page: 829 ident: bib13 article-title: Fatty liver and uric acid levels predict incident coronary heart disease but not stroke among atomic bomb survivors in Nagasaki publication-title: Hypertens Res – volume: 191 start-page: 235 year: 2007 end-page: 240 ident: bib34 article-title: Non-alcoholic fatty liver disease and increased risk of cardiovascular disease publication-title: Atherosclerosis – volume: 268 start-page: E1 year: 1995 end-page: E5 ident: bib21 article-title: Effect of insulin on uric acid excretion in humans publication-title: Am J Physiol – volume: 34 start-page: 204 year: 2002 end-page: 211 ident: bib11 article-title: Fasting insulin and uric acid levels but not indices of iron metabolism are independent predictors of non-alcoholic fatty liver disease. A case-control study publication-title: Dig Liver Dis – volume: 9 start-page: 746 year: 1996 ident: 10.1016/j.jhep.2008.11.021_bib22 article-title: Effect of insulin on renal sodium and uric acid handling in essential hypertension publication-title: Am J Hypertens doi: 10.1016/0895-7061(96)00098-2 – volume: 9 start-page: 28 year: 2002 ident: 10.1016/j.jhep.2008.11.021_bib24 article-title: Elevated serum leptin concentrations in women with hyperuricemia publication-title: J Atheroscler Thromb doi: 10.5551/jat.9.28 – volume: 270 start-page: 354 year: 1993 ident: 10.1016/j.jhep.2008.11.021_bib26 article-title: Uric acid metabolism and tubular sodium handling. Results from a population-based study publication-title: JAMA doi: 10.1001/jama.1993.03510030078038 – volume: 22 Suppl 2 start-page: 71 year: 2005 ident: 10.1016/j.jhep.2008.11.021_bib29 article-title: Review article: role of oxidative stress in the progression of non-alcoholic steatosis publication-title: Aliment Pharmacol Ther doi: 10.1111/j.1365-2036.2005.02601.x – volume: 22 start-page: 788 year: 2007 ident: 10.1016/j.jhep.2008.11.021_bib4 article-title: How common is non-alcoholic fatty liver disease in the Asia-Pacific region and are there local differences? publication-title: J Gastroenterol Hepatol doi: 10.1111/j.1440-1746.2007.05042.x – volume: 44 start-page: 581 year: 2006 ident: 10.1016/j.jhep.2008.11.021_bib30 article-title: Uric acid and anti-TNF antibody improve mitochondrial dysfunction in ob/ob mice publication-title: Hepatology doi: 10.1002/hep.21313 – volume: 191 start-page: 235 year: 2007 ident: 10.1016/j.jhep.2008.11.021_bib34 article-title: Non-alcoholic fatty liver disease and increased risk of cardiovascular disease publication-title: Atherosclerosis doi: 10.1016/j.atherosclerosis.2006.08.021 – volume: 37 start-page: 917 year: 2003 ident: 10.1016/j.jhep.2008.11.021_bib5 article-title: Nonalcoholic fatty liver, steatohepatitis, and the metabolic syndrome publication-title: Hepatology doi: 10.1053/jhep.2003.50161 – volume: 34 start-page: 204 year: 2002 ident: 10.1016/j.jhep.2008.11.021_bib11 article-title: Fasting insulin and uric acid levels but not indices of iron metabolism are independent predictors of non-alcoholic fatty liver disease. A case-control study publication-title: Dig Liver Dis doi: 10.1016/S1590-8658(02)80194-3 – volume: 22 start-page: 1141 year: 2005 ident: 10.1016/j.jhep.2008.11.021_bib1 article-title: Prevalence of non-alcoholic fatty liver disease and its association with impaired glucose metabolism in Japanese adults publication-title: Diabet Med doi: 10.1111/j.1464-5491.2005.01582.x – volume: 42 start-page: 473 year: 2005 ident: 10.1016/j.jhep.2008.11.021_bib33 article-title: Endothelial dysfunction and cardiovascular risk profile in nonalcoholic fatty liver disease publication-title: Hepatology doi: 10.1002/hep.20781 – volume: 283 start-page: 2404 year: 2000 ident: 10.1016/j.jhep.2008.11.021_bib18 article-title: Serum uric acid and cardiovascular mortality the NHANES I epidemiologic follow-up study, 1971-1992. National Health and Nutrition Examination Survey publication-title: JAMA doi: 10.1001/jama.283.18.2404 – volume: 5 start-page: 260 year: 2005 ident: 10.1016/j.jhep.2008.11.021_bib25 article-title: Endothelial effects of leptin: implications in health and diseases publication-title: Curr Diab Rep doi: 10.1007/s11892-005-0020-5 – volume: 30 start-page: 823 year: 2007 ident: 10.1016/j.jhep.2008.11.021_bib13 article-title: Fatty liver and uric acid levels predict incident coronary heart disease but not stroke among atomic bomb survivors in Nagasaki publication-title: Hypertens Res doi: 10.1291/hypres.30.823 – volume: 20 start-page: 125 year: 2005 ident: 10.1016/j.jhep.2008.11.021_bib7 article-title: Molecular physiology of urate transport publication-title: Physiology (Bethesda) doi: 10.1152/physiol.00039.2004 – volume: 120 start-page: 442 year: 2007 ident: 10.1016/j.jhep.2008.11.021_bib10 article-title: Prevalence of the metabolic syndrome in individuals with hyperuricemia publication-title: Am J Med doi: 10.1016/j.amjmed.2006.06.040 – volume: 49 start-page: 600 year: 2008 ident: 10.1016/j.jhep.2008.11.021_bib35 article-title: Non-alcoholic fatty liver disease is strongly associated with carotid atherosclerosis: A systematic review publication-title: J Hepatol doi: 10.1016/j.jhep.2008.06.012 – volume: 148 start-page: 131 year: 2000 ident: 10.1016/j.jhep.2008.11.021_bib27 article-title: Uric acid and serum antioxidant capacity: a reaction to atherosclerosis? publication-title: Atherosclerosis doi: 10.1016/S0021-9150(99)00214-2 – volume: 37 start-page: 1202 year: 2003 ident: 10.1016/j.jhep.2008.11.021_bib2 article-title: Nonalcoholic steatohepatitis: summary of an AASLD Single Topic Conference publication-title: Hepatology doi: 10.1053/jhep.2003.50193 – volume: 44 start-page: 512 year: 2003 ident: 10.1016/j.jhep.2008.11.021_bib32 article-title: Prooxidant and antioxidant properties of human serum ultrafiltrates toward LDL: important role of uric acid publication-title: J Lipid Res doi: 10.1194/jlr.M200407-JLR200 – volume: 41 start-page: 1183 year: 2003 ident: 10.1016/j.jhep.2008.11.021_bib36 article-title: Is there a pathogenetic role for uric acid in hypertension and cardiovascular and renal disease? publication-title: Hypertension doi: 10.1161/01.HYP.0000069700.62727.C5 – volume: 69 start-page: 928 year: 2005 ident: 10.1016/j.jhep.2008.11.021_bib8 article-title: Relationship between serum uric acid concentration and insulin resistance and metabolic syndrome publication-title: Circ J doi: 10.1253/circj.69.928 – volume: 30 start-page: 713 year: 1987 ident: 10.1016/j.jhep.2008.11.021_bib20 article-title: Elevated serum uric acid–a facet of hyperinsulinaemia publication-title: Diabetologia doi: 10.1007/BF00296994 – volume: 43 start-page: 508 year: 2005 ident: 10.1016/j.jhep.2008.11.021_bib3 article-title: Prevalence of and risk factors for fatty liver in a general population of Shanghai, China publication-title: J Hepatol doi: 10.1016/j.jhep.2005.02.042 – volume: 54 start-page: 3541 year: 2005 ident: 10.1016/j.jhep.2008.11.021_bib15 article-title: Nonalcoholic fatty liver disease and risk of future cardiovascular events among type 2 diabetic patients publication-title: Diabetes doi: 10.2337/diabetes.54.12.3541 – volume: 38 start-page: 365 year: 2001 ident: 10.1016/j.jhep.2008.11.021_bib28 article-title: Systemic uric acid administration increases serum antioxidant capacity in healthy volunteers publication-title: J Cardiovasc Pharmacol doi: 10.1097/00005344-200109000-00005 – volume: 41 start-page: 566 year: 2006 ident: 10.1016/j.jhep.2008.11.021_bib12 article-title: Obesity is the only independent factor associated with ultrasound-diagnosed non-alcoholic fatty liver disease: a cross-sectional case-control study publication-title: Scand J Gastroenterol doi: 10.1080/00365520500319591 – volume: 268 start-page: E1 year: 1995 ident: 10.1016/j.jhep.2008.11.021_bib21 article-title: Effect of insulin on uric acid excretion in humans publication-title: Am J Physiol – volume: 23 start-page: 469 year: 2006 ident: 10.1016/j.jhep.2008.11.021_bib14 article-title: Metabolic syndrome-a new world-wide definition. A Consensus Statement from the International Diabetes Federation publication-title: Diabet Med doi: 10.1111/j.1464-5491.2006.01858.x – volume: 1 start-page: 10 year: 2004 ident: 10.1016/j.jhep.2008.11.021_bib31 article-title: Uric acid: A new look at an old risk marker for cardiovascular disease, metabolic syndrome, and type 2 diabetes mellitus: The urate redox shuttle publication-title: Nutr Metab (Lond) doi: 10.1186/1743-7075-1-10 – volume: 48 start-page: 677 year: 1999 ident: 10.1016/j.jhep.2008.11.021_bib23 article-title: Serum leptin is associated with serum uric acid concentrations in humans publication-title: Metabolism doi: 10.1016/S0026-0495(99)90163-4 – volume: 42 start-page: 44 year: 2005 ident: 10.1016/j.jhep.2008.11.021_bib16 article-title: Prevalence of and risk factors for nonalcoholic fatty liver disease: the Dionysos nutrition and liver study publication-title: Hepatology doi: 10.1002/hep.20734 – volume: 34 start-page: 1882 year: 2007 ident: 10.1016/j.jhep.2008.11.021_bib9 article-title: Serum uric acid levels and risk for vascular diseases in patients with metabolic syndrome publication-title: J Rheumatol – volume: 22 start-page: 794 year: 2007 ident: 10.1016/j.jhep.2008.11.021_bib19 article-title: What are the risk factors and settings for non-alcoholic fatty liver disease in Asia-Pacific? publication-title: J Gastroenterol Hepatol doi: 10.1111/j.1440-1746.2007.04952.x – volume: 50 start-page: 1844 year: 2001 ident: 10.1016/j.jhep.2008.11.021_bib6 article-title: Nonalcoholic fatty liver disease: a feature of the metabolic syndrome publication-title: Diabetes doi: 10.2337/diabetes.50.8.1844 – volume: 47 start-page: 412 year: 2007 ident: 10.1016/j.jhep.2008.11.021_bib17 article-title: Nonalcoholic fatty liver disease in women with polycystic ovary syndrome publication-title: J Hepatol doi: 10.1016/j.jhep.2007.04.012 |
SSID | ssj0003094 |
Score | 2.4133286 |
Snippet | Serum uric acid level has been suggested to be associated with factors that contribute to the metabolic syndrome. The aim of this study was to investigate the... Background/Aim Serum uric acid level has been suggested to be associated with factors that contribute to the metabolic syndrome. The aim of this study was to... BACKGROUND/AIMSerum uric acid level has been suggested to be associated with factors that contribute to the metabolic syndrome. The aim of this study was to... |
SourceID | proquest pubmed pascalfrancis crossref elsevier |
SourceType | Aggregation Database Index Database Enrichment Source Publisher |
StartPage | 1029 |
SubjectTerms | Adult Association Biological and medical sciences Biomarkers - blood China - epidemiology Cross-Sectional Studies Fatty Liver - blood Fatty Liver - epidemiology Fatty Liver - ethnology Female Gastroenterology and Hepatology Gastroenterology. Liver. Pancreas. Abdomen Humans Liver. Biliary tract. Portal circulation. Exocrine pancreas Male Medical sciences Metabolic Syndrome - blood Metabolic Syndrome - epidemiology Metabolic Syndrome - ethnology Middle Aged Non-alcoholic fatty liver disease Other diseases. Semiology Prevalence Regression Analysis Risk Factors Uric acid Uric Acid - blood |
Title | Association of serum uric acid level with non-alcoholic fatty liver disease: A cross-sectional study |
URI | https://www.clinicalkey.com/#!/content/1-s2.0-S016882780800860X https://www.clinicalkey.es/playcontent/1-s2.0-S016882780800860X https://dx.doi.org/10.1016/j.jhep.2008.11.021 https://www.ncbi.nlm.nih.gov/pubmed/19299029 https://www.proquest.com/docview/67145109 |
Volume | 50 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1Lj9MwELZWi4SQEOJNeRQfuCFTx3HimFtVsSqPXSFgpd4sO3ZEV6WtSHrgwm9nJna6rGAXiVOkxKM44_H4c_zNDCEvame9CDowXyvFwPsF5lzumfBZLWqvPNcY73x8Us5P5btFsTggsyEWBmmVyfdHn95763RnkrQ52S6Xk88AVgAeKkyMCLicLzCCXSq08lc_z2keOdcpv3fFsHUKnIkcr7OvYRv5lJjJU2SXLU43t7YFlTWx1sXlYLRflI5uk1sJTdJp7PAdchDWd8n143Refo_437RPNw0Fe9t9o5hIiNp66ekKKUMU_8XS9WbNbKyXC08b23U_6ApJGzSd4bymU9p3m7U9fQtf3CenvU9Oj958mc1ZqqvAaql5x4rK1dZqq6UUTlhfV6Fy3nspnZKFz2GQKuvKsqkAPuTCc8s9LwqnYcYGEMofkEPoVHhEKLTKRCNkUzstC5ADvKCxqlXpLLdKj0g2KNTUKek41r5YmYFddmZwEGI1TNiLwCCMyMu9zDam3LiydT6MkxmCScH9GVgRrpRSf5MKbZrBrclMKww3f1jZiBR7yQuG-s83ji8Y0f7TBO5RFS9H5PlgVQamOJ7b2HXY7FpTKiynzEGZD6OxnatFI5oQ-vF_duoJuRFPx5DA-ZQcdt934RmArM6N-1k0Jtems08fPuL17fv5yS_A9yf7 |
linkProvider | Elsevier |
linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1Lb9QwELZKkQAJId4sj9YHbsis4zgPc6sqqgW6vdBKe7P8irrVsrsi2QMXfjszsbOlghaJa-KRnfHM-HP8eYaQt84aL4IKzLuqYhD9ArM290z4zAnnK88V3neenpSTM_l5Vsx2yOFwFwZplSn2x5jeR-v0ZJy0OV7P5-OvAFYAHlaYGBFwOZ_dIrcluC-WMXj_85LnkXOVEnzXDJunmzOR5HVxHtaRUImpPEV23ep0f21a0FkTi11cj0b7VenoIXmQ4CQ9iCN-RHbC8jG5M00H5k-I_039dNVQMLjNN4qZhKhxc08XyBmi-DOWLldLZmLBXHjbmK77QRfI2qDpEOcDPaD9sFnb87ew4z477VNydvTx9HDCUmEF5qTiHStq64xRRkkprDDe1aG23nspbSULn8Ms1caWZVMDfsiF54Z7XhRWgcsGEMqfkV0YVHhBKLTKRCNk46ySBcgBYFBY1qq0hptKjUg2KFS7lHUci18s9EAvu9A4CbEcJmxGYBJG5N1WZh1zbtzYOh_mSQ-3SSH-aVgSbpSq_iYV2uTCrc50KzTXf5jZiBRbySuW-s8e964Y0fbTBG5SK16OyP5gVRp8HA9uzDKsNq0uK6ynzEGZz6OxXapFIZwQ6uV_Dmqf3J2cTo_18aeTL6_IvXhUhmzO12S3-74JbwBxdXav96hfA-8n9A |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Association+of+serum+uric+acid+level+with+non-alcoholic+fatty+liver+disease%3A+a+cross-sectional+study&rft.jtitle=Journal+of+hepatology&rft.au=Li%2C+Youming&rft.au=Xu%2C+Chengfu&rft.au=Yu%2C+Chaohui&rft.au=Xu%2C+Lei&rft.date=2009-05-01&rft.eissn=1600-0641&rft.volume=50&rft.issue=5&rft.spage=1029&rft.epage=1034&rft_id=info:doi/10.1016%2Fj.jhep.2008.11.021&rft.externalDBID=NO_FULL_TEXT |
thumbnail_m | http://utb.summon.serialssolutions.com/2.0.0/image/custom?url=https%3A%2F%2Fcdn.clinicalkey.com%2Fck-thumbnails%2F01688278%2FS0168827809X00048%2Fcov150h.gif |